
The State Scientific Center "Institute of Immunology" of the Federal Medical and Biological Agency (FMBA) has submitted an application to the Ministry of HEALTH for registration of the drug against CORONAVIRUS "Mir-19", according to the data of the state register of medicines.
“The date of registration of the incoming number is October 14, 2021. Trade name - "Mir-19". The international non-proprietary name is synthetic small interfering ribonucleic acid (siRNA),” the report said.
The Ministry of Health estimated the timing of registration of the vaccine against covid-19 for adolescents
On October 15, clinical trials of the sixth coronavirus vaccine Betuvax started in St. Petersburg . Nikolay Kryuchkov, General DIRECTOR of the KEG BIO contract research company, specified to RBC that at the first stage of the research, 20 healthy volunteers will receive two doses of Betuvax with an interval of 28 days. According to him, this will allow specialists to assess the safety and immunogenicity of the vaccine. The next stage involves the introduction of the subjects not only the drug, but also a placebo, he added.
So far, five coronavirus vaccines have been registered in RUSSIA. Among them - "Sputnik V" and "Sputnik Light" of the Moscow Center. Gamaleya, "EpiVakKorona" and "EpiVakKorona-H" from the Novosibirsk center "Vector" and the drug "KoviVak" of the Center. Chumakov.
Mass vaccination against COVID-19 in Russia began in January 2021. As Minister of Health Mikhail Murashko previously clarified, more than 50 million adult Russians received at least one dose of the coronavirus vaccine in the country. According to RBC estimates for mid-September, residents of the Belgorod region were most actively vaccinated (44.19% of the population were fully vaccinated there), the Moscow region (42.47%) and Chukotka (42.3%). The lowest vaccination rate at that time was observed in Dagestan - 11.12%.